The aim of this study is to investigate associations between early structural cellular injury and microvascular alteration with progression of septic organ dysfunction according to total SOFA-Score (an ICU-scoring system - the Sequential Organ Failure Assessment Score). Patients will be monitored for renal (TIMP-2, IGFBP7), and intestinal biomarkers (plasma i-FABP) in conjunction with kidney and muscle vascular bed microvascular perfusion analysis assessed by contrast-enhanced ultrasonography (CEUS). In parallel, a comprehensive analysis of patients' immunological status will be conducted using an established, on-site immune monitoring panel. The ultimate goal of this study is an early identification of septic patients developing multiorgan dysfunction which may facilitate a timely novel intervention in the future to improve outcome.
Study Type
OBSERVATIONAL
Enrollment
25
Department of Surgery, University Hospital Regensburg
Regensburg, Bavaria, Germany
Assessment of early post-operative course of novel cellular injury biomarkers as well as microvascular perfusion in critically ill patients with severe sepsis and to collection any first evidence of the association of these markers with the SOFA-Score
Time frame: 60 weeks
28 day mortality
Time frame: 60 weeks
90 day mortality
Time frame: 60 weeks
Length of ICU stay
Time frame: 60 weeks
Length of hospital stay
Time frame: 60 weeks
Early post-operative course of microvascular perfusion of the kidney and muscle vasculature bed using CEUS
Time frame: 60 weeks
Incidence of acute kidney injury (AKI) within the first 48 hours as based on current Kidney Disease: Improving Global Outcomes (KDIGO) recommendation
Time frame: 60 weeks
Incidence of acute kidney injury (AKI) within the first 7 days as based on current Kidney Disease: Improving Global Outcomes (KDIGO) recommendation
Time frame: 60 weeks
Need for renal replacement therapy (RRT) after admission to ICU
Time frame: 60 weeks
Identification of an "immunological fingerprint" indicating multi-organ dysfunction
Flow cytometry
Time frame: 60 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.